Studies

Empirical research status Summary of scientific studies
on cannabis as medicine.

Cannabis as medicine: Scientific studies

   icon   
Medicinal cannabis has a number of mechanisms of action that can contribute to improving the quality of life of critically ill patients. Of particular relevance are the analgesic, antiemetic and appetite-inducing potentials.

The potential of cannabis in medicine has been demonstrated by numerous empirical studies and meta-analytical reviews. In the following we give an overview of the current scientific studies in relation to various indications.
shape1

Studies

Chronic pain

STUDY

Carter et al. (2014). Re-branding cannabis: the next generation of chronic pain medicine? Pain Management, 5(1), 13-21.

STUDY DESIGN

Metaanalysis/Review

INVESTIGATIONAL PRODUCT

Cannabis blossoms

RESULTS

Evidence of therapeutic options in chronic pain patients with cannabis or cannabis as a supplement to low opiate dose.



STUDY

Romero-Sandoval et al. (2017). Cannabis and Cannabinoids for Chronic Pain. Current Rheumatology Reports, 19(11), 67.

STUDY DESIGN

Metaanalysis/Review

INVESTIGATIONAL PRODUCT

Cannabis blossoms

RESULTS

– Inhaled cannabis is better tolerated
– Application can be better controlled pulmonarily than orally administered cannabinoids
– Inhaled cannabis blossoms lead to a decrease in non-tumor pain



STUDY

Bellnier et al. (2018). Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis. Mental Health Clinician, 8(3), 110-115.

STUDY DESIGN

Mirror-Image study (retrospective), N=29

INVESTIGATIONAL PRODUCT

Cannabis blossoms

RESULTS

– Medical cannabis improves quality of life
– Decrease of chronic pain and associated opiate intake
Neuropathic pain

STUDY

Wilsey et al. (2013). Lowdose vaporized cannabis significantly improves neuropathic pain. The Journal of Pain, 14(2), 136-148.

STUDY DESIGN

Cross-Over study (placebo-controlled, double-blind), N=39

INVESTIGATIONAL PRODUCT

Cannabis blossoms

RESULTS

– Significant pain reduction compared to placebo subjekts
– Low side effects due to cannabis-based therapy



STUDY

Eisenberg et al. (2014). The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered-Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study. Journal of Pain and Palliative Care Pharmacotherapy, 23(3), 216-225.

STUDY DESIGN


Phase-I-study, N=8

INVESTIGATIONAL PRODUCT

Cannabis blossoms

RESULTS

– Significant reduction of pain intensy
– Measured using visual analogue scale (VAS scale)



STUDY

Nugent et al. (2017). The Effects of Cannabis Among Adults with Chronic Pain and an Overview of General Harms: A Systematic Review. Ann Intern Med, 167, 319-331.

STUDY DESIGN

Metaanalysis/Review

INVESTIGATION PRODUCT

Cannabis blossoms

RESULTS

Cannabinoids can effectively relieve neuropathic pain.



STUDY

Lee et al. (2018). Medical Cannabis for Neuropathic Pain. Current Pain and Headache Reports, 22(1), 8.

STUDY DESIGN

Metaanalysis/Review of randomized and controlled studies, N=234
v

INVESTIGATIONAL PRODUCT

Cannabis extracts (inhaled)

RESULTS

Effective reduction of pain through cannabis-based therapy.
HIV-associated sensory neuropathy

STUDY

Abrams et al. (2007). Cannabis in painful HIV-associated sensory neuropathy A randomized placebo-controlled trial. Neurology, 68(7), 515-521.

STUDY

Randomized, placebo-controlled study (prospective), N=50

INVESTIGATIONAL PRODUCT

Cannabis blossoms

RESULTS

The cannabis therapy could reduce the pain sensation by 30% compared to the control group with placebo.
Palliative Oncology

STUDY

Johnson et al. (2010). Multicenter, doubleblind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage, 39:167-179.

STUDY DESIGN

Parallel group study (randomized, double-blind, placebo-controlled), N=177

INVESTIGATIONAL PRODUCT

Drugs containing cannabis

RESULTS

The cannabis therapy was able to significantly reduce the pain in cancer patients. In particular, patients who cannot be sufficiently painlessly treated with opioids benefit from additional medication with cannabinoids.



STUDY

Bar-Sela et al. (2013). The medical necessity for medicinal cannabis: prospective, observational study evaluating treatment in cancer patients on supportive or palliative care. Evidence-Based Complementary and Alternative Medicine, 510392.

STUDY DESIGN

Observational study (prospective), N=131

INVESTIGATIONAL PRODUCT

Cannabis blossoms

RESULTS

The cannabis therapy could significantly reduce the symptoms (CTAE scale).



STUDY

Waissengrin et al. (2015). Patterns of use of medical cannabis among Israeli cancer patients: a single institution experience. Journal of Pain and Symptom Management, 49(2), 223-230.

STUDY DESIGN

Observational study, N=69

INVESTIGATIONAL PRODUCT

Cannabis blossoms

RESULTS

The cannabis therapy could:

– reduce pain
– improve general well-being
– relieve nausea
– stimulate appetite
Nausea and vomiting during chemotherapy

STUDY

Sallan SE, Zinberg NE, Frei E. (1975). Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. New England Journal of Medicine, 293(16), 795-797.

STUDY DESIGN

Cross-over study (randomized, double-blind, placebo-kontrolled), N=20

INVESTIGATIONAL PRODUCT

Cannabis-based drugs

RESULTS

Antiemetic effect in subjects with cannabis compared to placebo.



STUDY

Duran et al. (2010). Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. British Journal of Clinical Pharmacology, 70(5), 656-663.

STUDY DESIGN

Phase-II-study (randomized, double-blind, placebo-controlled), N=7

INVESTIGATIONAL PRODUCT

Cannabis extract, CBD

RESULTS

The cannabis therapy increases the antiemetic effect of the standard therapy compared to the placebo.
Anorexia and cachexia: HIV/AIDS associated

STUDY

Beal et al. (1995). Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. Journal of pain and symptom management, 10(2), 89-97.

STUDY DESIGN

Parallel group study (randomizes, double-blind, placebo-controlled), N=139

INVESTIGATIONAL PRODUCT

Dronabinol/THC (oral)

RESULTS

– increase in appetite
– Reduction of nausea
– Twice as much weight gain was observed compared to pkacebo



STUDY

Haney et al. (2007). Dronabinol and marijuana in HIV-positive marijuana smokers: caloric intake, mood, and sleep. JAIDS Journal Acquired Immune Deficiency Syndromes 45(5), 545-554.

STUDY DESIGN

Within-Subject study (randomized, placebo-controlled), N=10

INVESTIGATIONAL PRODUCT

Cannabis blossoms and Dronabinol

RESULTS

Cannabis therapy leads to increased calorie intake.
Anorexia and Cachexia: In Chemotherapy

STUDY

Regelson et al. (1976). Delta-9-tetrahydrocannabinol as an effective antidepressant and appetite-stimulating agent in advanced cancer patients. Pharmacology of Marihuana, 2, 763-776.

STUDY DESIGN

Cross-over study (randomized, double-blind, placebo-controlled), N=10

INVESTIGATIONAL PRODUCT

THC (oral)
v

RESULTS

Cannabis therapy led to increased appetite.



STUDY

Whiting et al. (2015). Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA, 313:2456-2473.

STUDY DESIGN

Meta-analysis/review from 34 Studies

INVESTIGATIONAL PRODUCT

Cannabis blossoms and cannabis extract

RESULTS

Cannabis therapy led to:
– Reduction of central nervous pain in MS
– Reduction of pain caused by spasticity
Spasticity in multiple sclerosis

STUDY

Collin et al. (2010). A doubleblind, randomized, placebocontrolled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis. Neurological Research, 32(5), 451-459.

STUDY DESIGN

Between-Subject study (placebo-controlled, double-blind), N=337

INVESTIGATIONAL PRODUCT

Cannabis extract

RESULTS

Reduction of therapy-resistant spasticity.



STUDY

Corey-Bloom et al. (2012). Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. Canadian Medical Association Journal, 184(10), 1143-1150.

STUDY DESIGN

Cross-Over study (placebo-controlled), N=30

INVESTIGATIONAL PRODUCT

Cannabis blossoms

RESULTS

Therapy with cannabis blossoms led to reduction of spasticity, pain and exhaustion.



STUDY

Nielsen et al. (2018). The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: A Systematic Review of Reviews. Current Neurology and Neuroscience Reports, 18(2), 8.

STUDY DESIGN

Metaanalysis/review from 32 Studien

INVESTIGATIONAL PRODUCT

Cannabis-based drugs

RESULTS

Evidence for reduction of pain and spasticity in multiple sclerosis.
Central nervous pain in multiple sclerosis

STUDY

Whiting et al. (2015). Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA, 313:2456-2473.

STUDY DESIGN

Metaanalysis/review from 34 Studien

INVESTIGATIONAL PRODUCT

Cannabis blossoms and cannabis extract

RESULTS

Cannabis therapy led to:

– Reduction of central nervous pain in multiple sclerosis
– Reduction of pain caused by spasticity
studien_10head
studien_10txt
studien_11head
studien_11txt
studien_12head
studien_12txt
studien_13head
studien_13txt
studien_14head
studien_14txt
studien_15head
studien_15txt
studien_16head
studien_16txt
studien_17head
studien_17txt
studien_18head
studien_18txt
studien_19head
studien_19txt
studien_20head
studien_20txt
studien_21head
studien_21txt
studien_22head
studien_22txt
studien_23head
studien_23txt
studien_24head
studien_24txt
studien_25head
studien_25txt
studien_26head
studien_26txt
studien_27head
studien_27txt
studien_28head
studien_28txt
studien_29head
studien_29txt
studien_30head
studien_30txt
studien_31head
studien_31txt
studien_32head
studien_32txt
studien_33head
studien_33txt
studien_34head
studien_34txt
studien_35head
studien_35txt
studien_36head
studien_36txt
studien_37head
studien_37txt
studien_38head
studien_38txt
studien_39head
studien_39txt
studien_40head
studien_40txt
studien_41head
studien_41txt
studien_42head
studien_42txt
studien_43head
studien_43txt
studien_44head
studien_44txt
studien_45head
studien_45txt
studien_46head
studien_46txt
studien_47head
studien_47txt
studien_48head
studien_48txt
studien_49head
studien_49txt
studien_50head
studien_50txt
studien_51head
studien_51txt
studien_52head
studien_52txt
studien_53head
studien_53txt
studien_54head
studien_54txt
studien_55head
studien_55txt
studien_56head
studien_56txt
studien_57head
studien_57txt
studien_58head
studien_58txt
studien_59head
studien_59txt
studien_60head
studien_60txt
studien_61head
studien_61txt
studien_62head
studien_62txt
studien_63head
studien_63txt
studien_64head
studien_64txt
studien_65head
studien_65txt
studien_66head
studien_66txt
studien_67head
studien_67txt
studien_68head
studien_68txt
studien_69head
studien_69txt
studien_70head
studien_70txt
studien_71head
studien_71txt
studien_72head
studien_72txt
studien_73head
studien_73txt
studien_74head
studien_74txt
studien_75head
studien_75txt
studien_76head
studien_76txt
studien_77head
studien_77txt
studien_78head
studien_78txt
studien_79head
studien_79txt
studien_80head
studien_80txt
studien_81head
studien_81txt
studien_82head
studien_82txt
studien_83head
studien_83txt
studien_84head
studien_84txt
studien_85head
studien_85txt
studien_86head
studien_86txt
studien_87head
studien_87txt
studien_88head
studien_88txt
studien_89head
studien_89txt
studien_90head
studien_90txt
studien_91head
studien_91txt
studien_92head
studien_92txt
studien_93head
studien_93txt
studien_94head
studien_94txt
studien_95head
studien_95txt
studien_96head
studien_96txt
studien_97head
studien_97txt
studien_98head
studien_98txt
studien_99head
studien_99txt
shape1
shape3

Do you have any questions or suggestions?

icon
If you have any questions or suggestions, our team of experts will be happy to assist you and advise you further and individually on the scientific study situation regarding cannabis as medicine. We look forward to hearing from you!